enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q4 2025
Institutional positions in enGene Therapeutics Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +21 vs. Q3 2025
- Shares held
- 58.8M
- +17.9M (+43.9%) vs. Q3 2025
- Total value
- $530.8M
- +$251.8M (+90.2%) vs. Q3 2025
- New holders
- 27
- 17 more added
- Sold out
- 6
- 8 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 28 | $253 | 0.00% | −3−9.7% | Reduced |
| MAI Capital Management | 776 | $7.01K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,597 | $14.4K | 0.00% | +1,597 | New |
| Citigroup Inc | 1,688 | $15.2K | 0.00% | +1,687+168,700.0% | Added |
| JPMorgan Chase & Co | 2,614 | $23.6K | 0.00% | +2,614 | New |
| Royal Bank of Canada | 7,915 | $71.0K | 0.00% | 00.0% | Unchanged |
| PFS Partners, LLC | 11,000 | $99.3K | 0.05% | +2,000+22.2% | Added |
| Wells Fargo & Company | 11,217 | $101.3K | 0.00% | −6,693−37.4% | Reduced |
| Jump Financial, LLC | 13,400 | $121.0K | 0.00% | +13,400 | New |
| Schonfeld Strategic Advisors LLC | 16,645 | $150.3K | 0.00% | −8,425−33.6% | Reduced |
| Two Sigma Advisers, LP | 17,300 | $156.2K | 0.00% | +17,300 | New |
| Raymond James Financial Inc | 19,960 | $180.2K | 0.00% | +9,960+99.6% | Added |
| Renaissance Technologies LLC | 20,782 | $187.7K | 0.00% | +20,782 | New |
| XTX Topco Ltd | 23,922 | $216.0K | 0.01% | +23,922 | New |
| American Century Companies Inc | 23,980 | $216.5K | 0.00% | +23,980 | New |
| Pale Fire Capital SE | 24,004 | $216.8K | 0.03% | +6,750+39.1% | Added |
| Citadel Advisors LLC | 25,383 | $229.2K | 0.00% | −32,987−56.5% | Reduced |
| Geode Capital Management, LLC | 29,018 | $262.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 30,085 | $271.7K | 0.00% | −210−0.7% | Reduced |
| Virtus Investment Advisers, Inc. | 31,445 | $283.9K | 0.08% | +31,445 | New |
| BNP Paribas Arbitrage, SA | 35,877 | $324.0K | 0.00% | +35,877 | New |
| Quadrature Capital Ltd | 48,583 | $438.7K | 0.00% | +48,583 | New |
| Jane Street Group, LLC | 56,454 | $509.8K | 0.00% | +56,454 | New |
| HRT Financial LP | 64,380 | $581.0K | 0.00% | +64,380 | New |
| Kennedy Capital Management, Inc. | 76,765 | $693.2K | 0.01% | +76,765 | New |
| Deeter Investments LLP | 90,000 | $812.7K | 0.18% | +90,000 | New |
| Goldman Sachs Group Inc | 147,889 | $1.34M | 0.00% | +287+0.2% | Added |
| Two Sigma Investments, LP | 161,512 | $1.46M | 0.00% | +161,512 | New |
| DAFNA Capital Management LLC | 163,645 | $1.48M | 0.34% | +163,645 | New |
| Elmind Capital, LP | 210,000 | $1.90M | 0.56% | +210,000 | New |
| Woodline Partners LP | 250,000 | $2.26M | 0.01% | +250,000 | New |
| Monashee Investment Management LLC | 295,000 | $2.66M | 1.50% | +295,000 | New |
| ADAR1 Capital Management, LLC | 303,686 | $2.74M | 0.21% | +303,686 | New |
| Marshall Wace, LLP | 343,928 | $3.11M | 0.00% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 352,087 | $3.18M | 0.59% | +352,087 | New |
| Eversept Partners, LP | 455,835 | $4.12M | 0.23% | +455,835 | New |
| Point72 Asset Management, L.P. | 561,797 | $5.07M | 0.01% | −646,602−53.5% | Reduced |
| Affinity Asset Advisors, LLC | 643,370 | $5.81M | 0.42% | +566,370+735.5% | Added |
| Morgan Stanley | 718,485 | $6.49M | 0.00% | +283,194+65.1% | Added |
| Sr One Capital Management, LP | 747,750 | $6.75M | 0.96% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 876,357 | $7.91M | 2.76% | +350,000+66.5% | Added |
| Eventide Asset Management, LLC | 950,000 | $8.58M | 0.13% | +950,000 | New |
| Vestal Point Capital, LP | 1,055,000 | $9.53M | 0.35% | +685,000+185.1% | Added |
| Polar Capital Holdings Plc | 1,142,982 | $10.3M | 0.05% | +1,142,982 | New |
| Franklin Resources Inc | 1,388,000 | $12.5M | 0.00% | +350,000+33.7% | Added |
| Kynam Capital Management, LP | 1,492,898 | $13.5M | 0.88% | −3,501,192−70.1% | Reduced |
| Millennium Management LLC | 1,499,520 | $13.5M | 0.01% | +1,479,018+7,214.0% | Added |
| MPM Oncology Impact Management LP | 1,840,898 | $16.6M | 1.90% | +1,310,599+247.1% | Added |
| Janus Henderson Group PLC | 1,900,000 | $17.1M | 0.01% | +1,900,000 | New |
| Nextech Invest, Ltd. | 2,124,943 | $19.2M | 1.85% | +2,124,943 | New |
| Braidwell LP | 3,131,319 | $28.3M | 0.90% | +865,000+38.2% | Added |
| Siren, L.L.C. | 3,336,264 | $30.1M | 0.90% | +3,336,264 | New |
| Blue Owl Capital Holdings LP | 3,360,937 | $30.3M | 9.37% | +82,831+2.5% | Added |
| Cormorant Asset Management, LP | 4,000,000 | $36.1M | 2.05% | +1,676,405+72.1% | Added |
| Deep Track Capital, LP | 4,377,572 | $39.5M | 0.90% | +2,138,219+95.5% | Added |
| VR Adviser, LLC | 4,771,414 | $43.1M | 2.13% | −275,000−5.4% | Reduced |
| Perceptive Advisors LLC | 5,869,076 | $53.0M | 0.97% | +3,771,840+179.8% | Added |
| FCPM III Services B.V. | 9,632,561 | $87.0M | 11.40% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −1,157,380−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −647,192−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −504,409−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −11,074−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |